Location History:
- Osterweddingen, DE (2002 - 2004)
- Wahlitz, DE (2003 - 2009)
Company Filing History:
4 out of 4 
1 out of 2 
1 out of 7 
Years Active: 2002-2009
Title: Gerhard Fries: Innovator in Medicinal Chemistry
Introduction
Gerhard Fries is a notable inventor based in Wahlitz, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the area of kidney replacement therapy and diabetes treatment. With a total of 6 patents to his name, Fries has demonstrated a commitment to advancing medical science through innovative solutions.
Latest Patents
Fries' latest patents include groundbreaking inventions that focus on the use of a medicament containing an effector of the glutathione metabolism together with α-lipoic acid in kidney replacement therapy. This invention addresses the treatment of disturbances in cellular thiol status and related disorders. Another significant patent involves a medicament for treating diabetes mellitus, which combines an effector of the glutathione metabolism with α-lipoic acid. This formulation allows for the simultaneous or graduated treatment of thiol-disulfide status disturbances that occur in diabetes.
Career Highlights
Throughout his career, Gerhard Fries has worked with various companies, including Esparma GmbH. His work has been pivotal in developing new therapeutic approaches that enhance patient care and treatment outcomes.
Collaborations
Fries has collaborated with notable professionals in his field, including Dieter Koegst and Wolfgang A Wohlrab. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Gerhard Fries is a distinguished inventor whose work in medicinal chemistry has led to innovative solutions for kidney replacement therapy and diabetes treatment. His contributions continue to impact the medical field positively.